EMT | Epithelial–mesenchymal transition |
PRLR | Prolactin receptor |
DMFS | Distant metastasis-free survival |
TNBC | Triple-negative breast cancer |
HER-2 | Human epidermal growth factor receptor 2 |
TGFβ | Transforming growth factor beta |
EMT | Epithelial–mesenchymal transition |
PRLR | Prolactin receptor |
DMFS | Distant metastasis-free survival |
TNBC | Triple-negative breast cancer |
HER-2 | Human epidermal growth factor receptor 2 |
TGFβ | Transforming growth factor beta |